Baylor Dallas Opens Nation's First Neurosurgical OR Suite Featuring BrainSUITE iMRI, GE Healthcare MR Surgical ... ( DALLAS June 5 -- Baylor Univer...)

HOME >> MEDICINE >> NEWS

Baylor Dallas Opens Nation's First Neurosurgical OR Suite Featuring BrainSUITE iMRI, GE Healthcare MR Surgical Technology

Date:6/5/2009

DALLAS, June 5 /PRNewswire-USNewswire/ -- Baylor University Medical Center at Dallas is the first hospital in the country to collaborate with GE Healthcare and BrainLAB to open technically advanced neurosurgery operating room (OR) suites that will allow neurosurgeons to use real-time, intra-operative images of the brain during surgery. The $16.5 million operating suites will be the first to combine the BrainSUITE(R) iMRI and GE Healthcare MR Surgical Suite.

The four operating room suites opened this week and are equipped to use a high-definition magnetic resonance scanner and BrainSUITE iMRI navigation system that will help physicians more accurately view a tumor's location and remove diseased tissue.

"We're bringing together three leading health care companies to implement an innovative suite that will enhance the neurosurgeon's ability to provide quality neurosurgical care," said Christopher Michael, M.D., medical director for neurosurgical operating rooms, and neurosurgeon on the medical staff at Baylor Dallas.

The new technically advanced OR suite at Baylor Dallas will consist of two adjacent rooms specifically dedicated to neurological care. One room will be a neurosurgery operating theater while the other will be a neuroradiology room with a high-definition 1.5T magnetic resonance (MR) scanner. An advanced transport system between the two rooms allows patients to be moved from the OR to the MR scanner and back during surgery.

Three additional neurosurgical suites were also opened. The BrainSUITE iMRI navigation system links the operating room with real-time, intra-operative images of the brain from the MR scanner with the spatial position of the surgical instruments. This provides the physician a more accurate representation of the tumor's location and helps the physician verify the complete removal of a brain tumor during the actual surgery.

"The r
'/>"/>

SOURCE Baylor Health Care System
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Baylor Research Institute Receives Multi-Million Dollar Grant To Develop Flu Vaccine
2. Baylor Dallas Nationally Recognized for Nursing Excellence
3. Bill Lively Joins Baylor Health Care System Foundation as Senior Strategic Development Consultant
4. Bernard Brigonnet Joins Baylor Research Institute as Vice President and Chief Operating Officer
5. Evelyn Y. Davis, Shareholder Advocate, and the Evelyn Y. Davis Foundation Donate $100,000 to Riggs Emergency Department at Baylor University Medical Center at Dallas
6. National Quality Forum Names Baylor Health Care System Winner of 2008 NQF National Quality Healthcare Award
7. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
8. Baylor Health Care System Receives National Information Technology Recognition
9. Kenneth L. Reed, M.D. Performs First State of the Art AccuraScope(TM) Procedure in Dallas
10. Medical Facilities Among Finalists for Greater Dallas Business Ethics Awards
11. LocumTenens.com to Open Dallas Office, Names Robb Vice President

Post Your Comments:

(Date:7/14/2014)... (PRWEB) July 14, 2014 The ... increasing demand for clean energy, initiatives of associations ... the major factors which drive the growth of ... metals are used in various direct applications ranging ... and x-rays, among others. , North America is ...

(Date:7/14/2014)... 14, 2014)In the 2,500+ years that have passed ... Chinese, it has been used to treat a ... nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, ... just a few. Now, a meta-analysis of ... month in Menopause , the journal of ...

(Date:7/14/2014)... There’s an old adage that says first ... Palette say the products offered in their preorder event ... can reserve The Lash Palette for $40,” said Jenelle Paris, ... , Paris explained that the first 1,000 have already been ... She went on to point out that her company is ...

(Date:7/14/2014)... The governments in many countries are developing health ... Solutions market. For instance, in the US, Barack Obama's ... Clinical Health Act under the American Recovery and Reinvestment ... Global Mobile Health Solutions market will grow at ... According to the report, one of the prime drivers ...

(Date:7/14/2014)... has entered into an agreement with one of ... novel drug candidates for the detection and treatment ... in novel antibody discovery and Roche,s expertise in ... the possibility of improved treatment for cancer, a ... collaboration makes use of BTI,s discovery of a ...

Breaking Medicine News(10 mins):Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 2 Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 3 Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 4 Health News:Bothered by hot flashes? Acupuncture might be the answer 2 Health News:The Lash Palette Preorder Event Has Officially Begun 2 Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 2 Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 3 Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 4 Health News:A*STAR partners Roche to develop new cancer therapeutics 2

[0] North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor [0] Bothered by hot flashes? Acupuncture might be the answer [0] The Lash Palette Preorder Event Has Officially Begun [0] Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org [0] A*STAR partners Roche to develop new cancer therapeutics

... Aug. 7 /Xinhua-PRNewswire-FirstCall/ -- Aamaxan,Transport Group, Inc. ... AAXT),through its subsidiaries, including Shanghai Medical Technology ... a leading provider of Hemodialysis,equipment ("HDE") and ... diagnostic products, throughout Eastern China, today,announced the ...

... (Nasdaq:,MITI), a biopharmaceutical company focusing on the development ... inflammation and,autoimmune diseases, today announced its financial results ... 30, 2008., Summary of Recent Events:, ... update for the,BiTE(R) antibody blinatumomab (MT103/MEDI-538) at the ...

... - Annual revenue increases 5 percent to ... 76 percent to $3.64 and 11 percent to ... $23 billion, GAAP diluted, earnings per share from continuing operations increase 51 percent ... and 9 percent to $0.97 on a non-GAAP basis ...

... Calif., Aug. 7 The Board of Directors,of Endocare, ... 2008 an unsolicited,proposal from HealthTronics, Inc. (Nasdaq: HTRN ... common stock for $2.28 per share in cash., ... in consultation with its financial and legal advisors, will ...

... Consulting, a division of Gallagher Benefit Services, Inc., today announced the ... which examines current employee benefit trends and strategies. , ... ... division of Gallagher Benefit Services, Inc., today announced the release of ...

... Advice on Lap-Band Gastric Banding Procedure--Hundreds of Thousands with 30 ... Loss and to Ease Weight-Related Symptoms Including Diabetes, High Blood ... and Sleep Apnea. , ... Dallas ...

Shanghai Medical Technology Co., Appoints Chief Financial Officer Micromet, Inc. Reports Second Quarter 2008 Financial Results Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook Endocare Comments on Unsolicited Proposal Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting Lap-Band "Tell-All" Warns of Patients Becoming Lap-Band "Orphans"

(Date:7/14/2014)... July 14, 2014 More than any other generation, Millennials ... tablet computers -- but their eyes don,t. These mobile devices ... before, and the eye has not evolved to cope with ... eyes can do comfortably often results in tired eyes, focusing ... Digital Eye Strain. Now ZEISS has invented a new type ...

(Date:7/14/2014)... , July 14, 2014 Diomics, Inc., ... today announced that the United States Patent and ... by Diomics covering novel biologic sample collection materials, ... use in forensics and diagnostics. ... is by swabbing. Recovery of DNA from a ...

(Date:7/14/2014)... Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... that it will hold its 2014 Annual Meeting of Shareholders on Wednesday, ... held at No. 39 Shangdi Xi Road, Haidian District, Beijing ... will be eligible to vote and are invited to attend. ... Weidong Yin , Yuk Lam Lo , Simon Anderson ...

Breaking Medicine Technology:New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 2 New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 3 Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2 Sinovac Schedules 2014 Annual Meeting of Shareholders 2 Sinovac Schedules 2014 Annual Meeting of Shareholders 3

[0] New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives [0] Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics [0] Sinovac Schedules 2014 Annual Meeting of Shareholders

... Study for the Treatment of Advanced Prostate CancerPARSIPPANY, N.J., ... of a Phase IIIB clinical trial of degarelix for ... approved by the U.S. Food and Drug Administration (FDA) ... The announcement was made at the ...

... and EMERYVILLE, Calif., April 27 Bayer HealthCare Pharmaceuticals ... today announced that a Phase 3 trial evaluating Nexavar(R) ... stage IV melanoma was stopped early following a planned ... The trial was sponsored by the National Cancer ...

Cached Medicine Technology:Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 2 Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 3 Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 4 Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy 5 Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint 2 Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint 3 Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint 4 Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint 5

Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Drugs of Abuse Confirmation/Quantitation-Codeine, Free-Serum or Plasma Drugs of Abuse Confirmation/Quantitation-Cocaine & Metabolites-Meconium Drugs of Abuse Confirmation/Quantitation-Cannabinoids (9-carboxy-THC)-Urine Drugs of Abuse Confirmation/Quantitation-Benzodiazepines-Meconium